Review summary
Teaching objective: Prenatal care of a first pregnancy at 38 complicated by hyperemesis gravidarum, following ACOG Practice Bulletin 189 and RCOG Green-top Guideline 69 (1853): dating ultrasound; severity by the PUQE-24 score, weight, and hydration rather than urine ketones; electrolytes, magnesium, phosphate, liver tests, and thyroid tests with recognition of gestational transient thyrotoxicosis; stepwise antiemetics (doxylamine-pyridoxine, then metoclopramide, then ondansetron after counseling on the very small absolute risk of orofacial clefting); admission with intravenous saline and potassium, thiamine before any dextrose to prevent Wernicke encephalopathy, magnesium replacement, refeeding precautions, and weight-adjusted thromboprophylaxis; mental health screening with the PHQ-9 and EPDS; routine prenatal care at an advanced maternal age, with aneuploidy screening offered (cell-free DNA and nuchal translucency, with diagnostic testing available), low-dose aspirin for two moderate preeclampsia risk factors, and tuberculosis screening with an interferon-gamma release assay because of tuberculosis deaths in her household. The historical cause of her death is disputed and is recorded as conflicting retrospective claims, not decided by the modern episode.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| 21 April 1816 | Born in Thornton, Yorkshire. | CLM-0001 |
| 15 September 1821 | Her mother dies after a long illness. | CLM-0003, CLM-0004 |
| 1825 | Her elder sisters Maria and Elizabeth die. | CLM-0005 |
| 1847 | Jane Eyre published under the name Currer Bell. | CLM-0002 |
| 1848 | Her brother Branwell and her sister Emily die. | CLM-0006, CLM-0007 |
| 28 May 1849 | Her sister Anne dies of tuberculosis. | CLM-0007 |
| 29 June 1854 | Marries at Haworth. | CLM-0008 |
| November 1854 | Lingering cold and sore throat after a walk in the rain. | CLM-0009 |
| January 1855 | Onset of perpetual nausea and faintness. | CLM-0010 |
| 15 February 1855 | Writes that she has been confined to bed for three weeks; the household servant dies about this time. | CLM-0011, CLM-0012, CLM-0015 |
| Third week of March 1855 | Low wandering delirium; she asks for food. | CLM-0013, CLM-0017 |
| 31 March 1855 | Dies at Haworth; the death certificate gives phthisis, and other causes are proposed later. | CLM-0013, CLM-0014, CLM-0016, CLM-0018, CLM-0019, CLM-0020 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Charlotte Brontë was born on 21 April 1816 in Thornton, Yorkshire, the third of six children of Maria Branwell and her husband, an Anglican clergyman. | confirmed | Charlotte Brontë supports |
| D | Jane Eyre was first published in 1847 under the pseudonym Currer Bell. | confirmed | Charlotte Brontë supports |
| D | Her mother died on 15 September 1821, in the 39th year of her age, after a long and painful illness. | confirmed | Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports Charlotte Brontë supports |
| R | Her mother's illness may have been cancer; one reference work says uterine cancer. The cause is a later interpretation. Recorded as possible only. |
possible | Charlotte Brontë supports Brontë family supports |
| D | Her two elder sisters, Maria and Elizabeth, fell ill at the Clergy Daughters' School at Cowan Bridge and died at home in 1825, Maria on 6 May aged 11 and Elizabeth on 15 June aged 10; reference works give tuberculosis. The causes are as given by the reference works; the school also had an outbreak of typhus. |
probable | Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports Charlotte Brontë supports Brontë family supports |
| D | Her brother Branwell died on 24 September 1848, aged 31, of several conditions made worse by heavy drinking; tuberculosis is listed among them. Family history only. |
probable | Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports Charlotte Brontë supports Brontë family supports |
| D | Her sisters Emily and Anne died of tuberculosis, Emily on 19 December 1848 aged 30 and Anne on 28 May 1849 aged 29. Household tuberculosis deaths; the reason for tuberculosis screening in the synthetic episode. |
confirmed | Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports Charlotte Brontë supports |
| D | On 29 June 1854 she married Arthur Bell Nicholls, her father's curate, at Haworth. | confirmed | Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports Charlotte Brontë supports |
| D | In late November 1854, after a long walk on the moors to a waterfall that ended in heavy rain, she began to shiver and had a bad lingering sore throat and cold that made her thin and weak. An intercurrent illness before the final one, in Gaskell's account. |
confirmed | Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports |
| D | Early in 1855, after a visit to Gawthorpe and a long walk over damp ground in thin shoes, she was attacked by "new sensations of perpetual nausea, and ever-recurring faintness"; a doctor who was called assigned a natural cause for her indisposition. The onset of the final illness, in Gaskell's account. |
confirmed | Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports |
| D | The sickness increased until the very sight of food caused nausea. On 15 February 1855 she wrote that she had been confined to bed for three weeks, that up to then she had had excellent health since her marriage, and that she was much reduced and very weak. | confirmed | Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports |
| D | Tabitha Ackroyd, the family's elderly servant, died during Charlotte's illness; a literary historian writes that she died of a digestive infection six weeks before Charlotte. Context for the infectious explanations in CLM-0018. |
probable | Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports Gezari J. The death of Charlotte Brontë supports |
| D | About the third week of March 1855 a low wandering delirium came on, in which she begged constantly for food; she died early on Saturday 31 March 1855 at Haworth, in the 39th year of her age. Record the death as a fact without detail. |
confirmed | Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 supports Charlotte Brontë supports |
| D | Her death certificate gave the cause of death as phthisis, a term for pulmonary tuberculosis. | confirmed | Charlotte Brontë supports Gezari J. The death of Charlotte Brontë supports Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 supports |
| D | She is widely reported to have been in the early stages of pregnancy when she died; Gaskell records that her servant cheered her with the thought of the baby that was coming, and a letter of hers suggests that she was pregnant. The death certificate does not mention pregnancy. The anchor for the synthetic first pregnancy. |
probable | Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 supports Charlotte Brontë supports Gezari J. The death of Charlotte Brontë supports |
| R | Hyperemesis gravidarum has been proposed as the cause of her final illness and death. Retrospective diagnosis; the synthetic episode teaches its modern management without asserting it as her diagnosis. |
possible | Charlotte Brontë supports Brontë family supports Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 supports Gezari J. The death of Charlotte Brontë context |
| R | A 2019 clinical nutrition paper agrees that hyperemesis gravidarum is the most likely diagnosis and suggests that the refeeding syndrome, after her appetite returned in the third week of March, caused her death; it argues there is no more than circumstantial evidence for tuberculosis and that Addison's disease fits poorly. Retrospective interpretation; abstract read. |
possible | Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 supports |
| R | A bacterial infection such as typhoid has also been suggested, possibly caught from the servant who died weeks earlier. Retrospective interpretation. |
possible | Gezari J. The death of Charlotte Brontë supports Brontë family supports |
| R | A 1991 obstetrics paper doubts that she was ever pregnant and argues that tuberculosis with secondary Addison disease explains her terminal illness. Retrospective interpretation; abstract read. |
disputed | Weiss G. The death of Charlotte Brontë. Obstet Gynecol. 1991;78(4):705-708 supports |
| R | Tuberculosis as the cause of her death, as the death certificate records, is disputed; the diagnosis was made without modern tests, and later writers have proposed hyperemesis gravidarum, refeeding syndrome, typhoid, and Addison disease instead. The diagnostic conflict is recorded, not resolved. |
disputed | Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 supports Weiss G. The death of Charlotte Brontë. Obstet Gynecol. 1991;78(4):705-708 supports Charlotte Brontë context |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | First pregnancy at 38 (elderly primigravida), single live intrauterine pregnancy dated by ultrasound at 7 weeks 1 day | active | confirmed | active | CLM-0015, CLM-0016 |
| S | Nausea and vomiting of pregnancy, moderate (PUQE-24 score 10), with early weight loss, under evaluation for hyperemesis gravidarum | resolved | confirmed | active | CLM-0010, CLM-0011, CLM-0016, CLM-0017 |
| S | Hyperemesis gravidarum with metabolic disturbance: unable to keep fluids down, 7.4 percent weight loss, dehydration, hypokalemia, hyponatremia, hypochloremic alkalosis, low magnesium, and raised transaminases; PUQE-24 score 14 | active | confirmed | both_with_link | CLM-0010, CLM-0011, CLM-0016, CLM-0017 |
| S | Gestational transient thyrotoxicosis: suppressed TSH and mildly raised free T4 with hyperemesis, no goiter, eye signs, or tremor; no treatment needed | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1855-01-13 | Hemoglobin [Mass/volume] in Blood | 12.8 g/dL Reference 11-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 1855-01-13 | Leukocytes [#/volume] in Blood by Automated count | 8.4 10*3/uL Reference 4-13 10*3/uL |
http://loinc.org · 6690-2 |
| S | 1855-01-13 | Platelets [#/volume] in Blood by Automated count | 248 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1855-01-13 | Sodium [Moles/volume] in Serum or Plasma | 137 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1855-01-13 | Potassium [Moles/volume] in Serum or Plasma | 3.9 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1855-01-13 | Chloride [Moles/volume] in Serum or Plasma | 102 mmol/L Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1855-01-13 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 24 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1855-01-13 | Urea nitrogen [Mass/volume] in Serum or Plasma | 8 mg/dL Reference 6-20 mg/dL |
http://loinc.org · 3094-0 |
| S | 1855-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.52 mg/dL Reference 0.4-0.9 mg/dL |
http://loinc.org · 2160-0 |
| S | 1855-01-13 | Glucose [Mass/volume] in Serum or Plasma | 76 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1855-01-13 | Ketones [Mass/volume] in Urine by Test strip | 15 mg/dL (high) Reference <=0 mg/dL |
http://loinc.org · 5797-6 |
| S | 1855-01-13 | Fetal Crown Rump length US | 11 mm Reference Consistent with 7 weeks 1 day by the last menstrual period |
http://loinc.org · 11957-8 |
| S | 1855-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | http://loinc.org · 44261-6 |
| S | 1855-01-20 | Sodium [Moles/volume] in Serum or Plasma | 136 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1855-01-20 | Potassium [Moles/volume] in Serum or Plasma | 3.6 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1855-01-20 | Chloride [Moles/volume] in Serum or Plasma | 99 mmol/L Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1855-01-20 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 26 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1855-01-20 | Urea nitrogen [Mass/volume] in Serum or Plasma | 11 mg/dL Reference 6-20 mg/dL |
http://loinc.org · 3094-0 |
| S | 1855-01-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.58 mg/dL Reference 0.4-0.9 mg/dL |
http://loinc.org · 2160-0 |
| S | 1855-01-20 | Glucose [Mass/volume] in Serum or Plasma | 74 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1855-01-20 | Ketones [Mass/volume] in Urine by Test strip | 40 mg/dL (high) Reference <=0 mg/dL |
http://loinc.org · 5797-6 |
| S | 1855-01-29 | Hemoglobin [Mass/volume] in Blood | 14.1 g/dL Reference 11-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 1855-01-29 | Sodium [Moles/volume] in Serum or Plasma | 133 mmol/L (low) Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1855-01-29 | Potassium [Moles/volume] in Serum or Plasma | 3.1 mmol/L (low) Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1855-01-29 | Chloride [Moles/volume] in Serum or Plasma | 94 mmol/L (low) Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1855-01-29 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 31 mmol/L (high) Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1855-01-29 | Urea nitrogen [Mass/volume] in Serum or Plasma | 21 mg/dL (high) Reference 6-20 mg/dL |
http://loinc.org · 3094-0 |
| S | 1855-01-29 | Creatinine [Mass/volume] in Serum or Plasma | 0.71 mg/dL Reference 0.4-0.9 mg/dL |
http://loinc.org · 2160-0 |
| S | 1855-01-29 | Glucose [Mass/volume] in Serum or Plasma | 68 mg/dL (low) Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1855-01-29 | Magnesium [Mass/volume] in Serum or Plasma | 1.6 mg/dL (low) Reference 1.7-2.2 mg/dL |
http://loinc.org · 19123-9 |
| S | 1855-01-29 | Phosphate [Mass/volume] in Serum or Plasma | 2.6 mg/dL Reference 2.5-4.5 mg/dL |
http://loinc.org · 2777-1 |
| S | 1855-01-29 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 66 U/L (high) Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1855-01-29 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 49 U/L (high) Reference 10-35 U/L |
http://loinc.org · 1920-8 |
| S | 1855-01-29 | Thyrotropin [Units/volume] in Serum or Plasma | 0.03 mIU/L (low) Reference 0.1-2.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 1855-01-29 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma | 2.1 ng/dL (high) Reference 0.8-1.8 ng/dL |
http://loinc.org · 3024-7 |
| S | 1855-01-29 | Ketones [Mass/volume] in Urine by Test strip | 80 mg/dL (high) Reference <=0 mg/dL |
http://loinc.org · 5797-6 |
| S | 1855-02-10 | Sodium [Moles/volume] in Serum or Plasma | 137 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1855-02-10 | Potassium [Moles/volume] in Serum or Plasma | 4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1855-02-10 | Chloride [Moles/volume] in Serum or Plasma | 101 mmol/L Reference 98-107 mmol/L |
http://loinc.org · 2075-0 |
| S | 1855-02-10 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 25 mmol/L Reference 22-29 mmol/L |
http://loinc.org · 2028-9 |
| S | 1855-02-10 | Urea nitrogen [Mass/volume] in Serum or Plasma | 9 mg/dL Reference 6-20 mg/dL |
http://loinc.org · 3094-0 |
| S | 1855-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 0.55 mg/dL Reference 0.4-0.9 mg/dL |
http://loinc.org · 2160-0 |
| S | 1855-02-10 | Glucose [Mass/volume] in Serum or Plasma | 82 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1855-02-10 | Magnesium [Mass/volume] in Serum or Plasma | 1.9 mg/dL Reference 1.7-2.2 mg/dL |
http://loinc.org · 19123-9 |
| S | 1855-02-10 | Phosphate [Mass/volume] in Serum or Plasma | 3.4 mg/dL Reference 2.5-4.5 mg/dL |
http://loinc.org · 2777-1 |
| S | 1855-02-10 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1855-02-10 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference 10-35 U/L |
http://loinc.org · 1920-8 |
| S | 1855-02-10 | Total score [EPDS] | 9 | http://loinc.org · 99046-5 |
| S | 1855-02-24 | Fetal Crown Rump length US | 70 mm Reference Consistent with 13 weeks 1 day by the dating scan |
http://loinc.org · 11957-8 |
| S | 1855-02-24 | Fetal nuchal translucency measured by US | 1.5 mm Reference <=3.5 mm |
http://loinc.org · 33069-6 |
| S | 1855-03-24 | Hemoglobin [Mass/volume] in Blood | 11.6 g/dL Reference 11-15.5 g/dL |
http://loinc.org · 718-7 |
| S | 1855-03-24 | Thyrotropin [Units/volume] in Serum or Plasma | 0.92 mIU/L Reference 0.2-3 mIU/L |
http://loinc.org · 3016-3 |
| S | 1855-03-24 | Thyroxine (T4) free [Mass/volume] in Serum or Plasma | 1.1 ng/dL Reference 0.8-1.8 ng/dL |
http://loinc.org · 3024-7 |
| S | 1855-03-24 | Total score [EPDS] | 5 | http://loinc.org · 99046-5 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1855-01-13 | Body height | 152 cm | 8302-2 | S |
| 1855-01-13 | Body weight | 45.1 kg | 29463-7 | S |
| 1855-01-13 | Body mass index (BMI) [Ratio] | 19.5 kg/m2 | 39156-5 | S |
| 1855-01-13 | Systolic blood pressure | 104 mm[Hg] | 8480-6 | S |
| 1855-01-13 | Diastolic blood pressure | 66 mm[Hg] | 8462-4 | S |
| 1855-01-13 | Heart rate | 84 /min | 8867-4 | S |
| 1855-01-13 | Respiratory rate | 14 /min | 9279-1 | S |
| 1855-01-13 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1855-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1855-01-20 | Body height | 152 cm | 8302-2 | S |
| 1855-01-20 | Body weight | 44 kg | 29463-7 | S |
| 1855-01-20 | Body mass index (BMI) [Ratio] | 19 kg/m2 | 39156-5 | S |
| 1855-01-20 | Systolic blood pressure | 102 mm[Hg] | 8480-6 | S |
| 1855-01-20 | Diastolic blood pressure | 64 mm[Hg] | 8462-4 | S |
| 1855-01-20 | Heart rate | 92 /min | 8867-4 | S |
| 1855-01-20 | Respiratory rate | 14 /min | 9279-1 | S |
| 1855-01-20 | Body temperature | 36.8 Cel | 8310-5 | S |
| 1855-01-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1855-01-29 | Body height | 152 cm | 8302-2 | S |
| 1855-01-29 | Body weight | 42.6 kg | 29463-7 | S |
| 1855-01-29 | Body mass index (BMI) [Ratio] | 18.4 kg/m2 | 39156-5 | S |
| 1855-01-29 | Systolic blood pressure | 96 mm[Hg] | 8480-6 | S |
| 1855-01-29 | Diastolic blood pressure | 60 mm[Hg] | 8462-4 | S |
| 1855-01-29 | Heart rate | 108 /min | 8867-4 | S |
| 1855-01-29 | Respiratory rate | 16 /min | 9279-1 | S |
| 1855-01-29 | Body temperature | 36.9 Cel | 8310-5 | S |
| 1855-01-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1855-02-10 | Body height | 152 cm | 8302-2 | S |
| 1855-02-10 | Body weight | 43.6 kg | 29463-7 | S |
| 1855-02-10 | Body mass index (BMI) [Ratio] | 18.9 kg/m2 | 39156-5 | S |
| 1855-02-10 | Systolic blood pressure | 104 mm[Hg] | 8480-6 | S |
| 1855-02-10 | Diastolic blood pressure | 64 mm[Hg] | 8462-4 | S |
| 1855-02-10 | Heart rate | 86 /min | 8867-4 | S |
| 1855-02-10 | Respiratory rate | 14 /min | 9279-1 | S |
| 1855-02-10 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1855-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1855-02-24 | Body height | 152 cm | 8302-2 | S |
| 1855-02-24 | Body weight | 44.4 kg | 29463-7 | S |
| 1855-02-24 | Body mass index (BMI) [Ratio] | 19.2 kg/m2 | 39156-5 | S |
| 1855-02-24 | Systolic blood pressure | 106 mm[Hg] | 8480-6 | S |
| 1855-02-24 | Diastolic blood pressure | 66 mm[Hg] | 8462-4 | S |
| 1855-02-24 | Heart rate | 82 /min | 8867-4 | S |
| 1855-02-24 | Respiratory rate | 14 /min | 9279-1 | S |
| 1855-02-24 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1855-02-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1855-03-24 | Body height | 152 cm | 8302-2 | S |
| 1855-03-24 | Body weight | 46.2 kg | 29463-7 | S |
| 1855-03-24 | Body mass index (BMI) [Ratio] | 20 kg/m2 | 39156-5 | S |
| 1855-03-24 | Systolic blood pressure | 108 mm[Hg] | 8480-6 | S |
| 1855-03-24 | Diastolic blood pressure | 68 mm[Hg] | 8462-4 | S |
| 1855-03-24 | Heart rate | 80 /min | 8867-4 | S |
| 1855-03-24 | Respiratory rate | 14 /min | 9279-1 | S |
| 1855-03-24 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1855-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: novelist who writes at home in the mornings; her most recent novels were widely read
- S Married seven months ago; lives with her husband and her elderly father in a stone house beside the church at the edge of the moors; neither is named in this record; the pregnancy was planned and is wanted
- S Never smoked; no alcohol since before conception; no drug use; one cup of tea a day
- S Walked on the moors most days until the nausea began; feels safe at home, and the screen for intimate partner violence is negative
- S Supports: her husband, a close friend from school days with whom she writes often, and the household's long-serving help
Functional status
- S Until a week ago she ran the household and wrote each morning; now she lies down most afternoons and has stopped writing; she keeps down small sips and dry crackers
Mental status
- S Small and slight, neatly dressed, quietly spoken and articulate; tired; mood "worn out, but glad"; anxious about carrying a first pregnancy at her age after losing her mother and sisters young; no thoughts of self-harm; PHQ-9 score 5
Allergies and medications
Allergies
- S No known allergy
Medications
- S Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe)
- S Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, two tablets by mouth at bedtime
- S Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, one tablet in the morning, one mid-afternoon, and two at bedtime (four a day)
- S Metoclopramide 10 mg oral tablet, one tablet by mouth three times a day before meals
- S Sodium chloride 0.9% with potassium chloride 20 mmol per liter, 1000 mL intravenously over 8 hours
- S Thiamine 100 mg intravenously daily, the first dose before any dextrose
- S Ondansetron 4 mg intravenously every 8 hours
- S Enoxaparin 20 mg subcutaneously once daily during the admission (weight under 50 kg)
- S Magnesium sulfate 2 g in 50 mL intravenously over 1 hour, once
- S Ondansetron 4 mg orally disintegrating tablet, one tablet every 8 hours
- S Ondansetron 4 mg orally disintegrating tablet, one tablet every 8 hours as needed for nausea
- S Thiamine 100 mg oral tablet, one tablet by mouth three times a day
- S Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime
Procedures and immunizations
Procedures
- S Transvaginal dating ultrasound: single live intrauterine pregnancy, crown-rump length 11 mm (7 weeks 1 day), cardiac activity present, no subchorionic hemorrhage, ovaries normal
- S 12-lead electrocardiogram before intravenous ondansetron with hypokalemia: sinus tachycardia 106 per minute, QTc 438 ms, no other abnormality
- S First-trimester ultrasound for nuchal translucency: single live fetus, crown-rump length 70 mm (13 weeks 1 day), nuchal translucency 1.5 mm, nasal bone present, no structural abnormality seen
Immunizations
- S 1855-01-13: Influenza vaccine, 1854-1855 season, given in pregnancy
- S 1848-05-14: Tdap vaccine
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D November 1854: A bad lingering sore throat and cold after a long walk in heavy rain on the moors, which made her thin and weak (CLM-0009)
Family history
- R mother: Died in 1821 in her 39th year after a long and painful illness, possibly cancer
- D sister: Eldest sister: tuberculosis after illness at boarding school; died in 1825 aged 11
- D sister: Second sister: tuberculosis after illness at boarding school; died in 1825 aged 10
- D brother: Died in 1848 aged 31 of several conditions made worse by heavy drinking, with tuberculosis among them
- D sister: Tuberculosis; died in 1848 aged 30
- D sister: Tuberculosis; died in 1849 aged 29
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Nausea and vomiting mild (PUQE-24 score 6 or less) and weight back to her pre-pregnancy 46.0 kg by about 17 weeks | 1855-03-24 | completed | PUQE-24 score 4 and weight 46.2 kg at 17 weeks 1 day |
| Hydration and electrolytes normal within two weeks of any admission | 1855-02-10 | completed | Sodium, potassium, chloride, bicarbonate, magnesium, phosphate, and transaminases all normal nine days after discharge |
| An informed choice about aneuploidy screening and diagnostic testing by 13 weeks | 1855-02-24 | completed | Chose cell-free DNA screening (low risk) and the nuchal translucency scan (1.5 mm); declined diagnostic testing |
| Low-dose aspirin started between 12 and 16 weeks if indicated | 1855-02-24 | completed | Started at 13 weeks 1 day for two moderate risk factors |
| Tuberculosis screening completed and explained by the second visit | 1855-01-20 | completed | Interferon-gamma release assay negative; no latent infection; no chest radiograph needed |
| Mood screened in each trimester, with support offered | 1855-03-24 | completed | PHQ-9 5 at intake, EPDS 9 after the admission and 5 at 17 weeks; item 10 scored 0 each time |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| First prenatal visit: dating ultrasound; blood count, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture; metabolic panel and urinalysis because of vomiting; influenza vaccine; folic acid 0.4 mg daily in place of the iron-containing prenatal vitamin while nausea lasts | completed | GL-USPSTF-AB, GL-CDC-PREGVAX |
| Nausea and vomiting, step by step: small frequent dry meals, fluids between meals, ginger if she wishes, and avoiding smells that trigger nausea; doxylamine-pyridoxine from today, raised to four tablets a day if needed; then a second drug (metoclopramide, promethazine, or ondansetron after counseling); PUQE-24 score, weight, pulse, blood pressure, and electrolytes at each visit; same-day review if she cannot keep fluids down for 24 hours or loses more than 5 percent of her pre-pregnancy weight | completed | GL-ACOG-NVP-2018, GL-RCOG-HG-2024 |
| Maternal-fetal medicine consultation for a first pregnancy at 38 with moderate nausea and vomiting and early weight loss: escalation thresholds, aneuploidy screening and diagnostic options, preeclampsia prevention, tuberculosis risk, and the plan for the rest of the pregnancy | completed | GL-ACOG-NVP-2018, GL-RCOG-HG-2024, GL-ACOG-ANEU-2020, GL-USPSTF-ASA-2021 |
| Aneuploidy screening offered to all, with diagnostic testing available: cell-free DNA from 10 weeks, a nuchal translucency scan at 11 to 14 weeks, or chorionic villus sampling or amniocentesis; a detailed anatomy scan at 18 to 22 weeks | completed | GL-ACOG-ANEU-2020 |
| Tuberculosis screening with an interferon-gamma release assay because of tuberculosis deaths in her household; a shielded chest radiograph and treatment decisions only if it is positive | completed | GL-USPSTF-LTBI-2023 |
| Mental health: PHQ-9 at intake and the EPDS in each trimester and after any admission, with support for the strain of severe vomiting and for anxiety rooted in family loss | completed | GL-ACOG-MH-2023, GL-USPSTF-PND-2019 |
| Preeclampsia prevention: low-dose aspirin 81 mg at bedtime from 12 to 16 weeks until delivery if she has one high-risk or more than one moderate-risk factor (she has two: first pregnancy and age 35 or older); blood pressure at every visit | completed | GL-USPSTF-ASA-2021 |
| Admission for hyperemesis gravidarum: 0.9% saline with potassium chloride guided by daily electrolytes; thiamine 100 mg intravenously before any dextrose, then orally; magnesium replacement; ondansetron after counseling and an electrocardiogram; stop metoclopramide; refeeding precautions with phosphate and magnesium checks as eating resumes; weight-adjusted enoxaparin while admitted; discharge when she keeps fluids and food down | completed | GL-ACOG-NVP-2018, GL-RCOG-HG-2024, GL-RCOG-VTE-2015 |
| Thyroid: suppressed TSH with a mildly raised free T4 during hyperemesis is gestational transient thyrotoxicosis; no antithyroid drug; repeat TSH and free T4 at 16 to 18 weeks, and test for TSH-receptor antibodies only if it persists or signs of Graves disease appear | completed | GL-ATA-PREG-2017, GL-ACOG-NVP-2018 |
| Monitoring while nausea and vomiting last: PUQE-24, weight, pulse, and blood pressure at every visit; electrolytes until stable on oral intake; liver tests if abnormal; mood each trimester; antiemetic side effects (drowsiness, restlessness or abnormal movements, constipation, palpitations) | completed | GL-ACOG-NVP-2018, GL-RCOG-HG-2024 |
Planned encounters
- 1855-01-13 — First prenatal visit at 7 weeks with nausea and vomiting for a week and early weight loss: dating ultrasound, prenatal tests, and a plan for the nausea (ENC-001)
- 1855-01-20 — One-week review of nausea and vomiting, intake results, and maternal-fetal medicine consultation (ENC-002)
- 1855-01-29 — Same-day sick visit for vomiting with dehydration at 9 weeks, with direct admission (ENC-006, unscheduled)
- 1855-02-10 — Prenatal visit at 11 weeks: nausea and vomiting review and cell-free DNA screening (ENC-003)
- 1855-02-24 — Prenatal visit at 13 weeks with the nuchal translucency scan and the low-dose aspirin decision (ENC-004)
- 1855-03-24 — Prenatal visit at 17 weeks: nausea and vomiting review and thyroid recheck (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Sick Visit
- Progress note 04 — Focused Visit (Follow-up)
- Progress note 05 — Focused Visit (Follow-up)
- Progress note 06 — Focused Visit (Care-plan review)
- Maternal-Fetal Medicine referral
- Maternal-Fetal Medicine consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Sick Visit (XML)
- Progress note 04 — Focused Visit (Follow-up) (XML)
- Progress note 05 — Focused Visit (Follow-up) (XML)
- Progress note 06 — Focused Visit (Care-plan review) (XML)
- Maternal-Fetal Medicine referral (XML)
- Maternal-Fetal Medicine consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Gaskell EC. The Life of Charlotte Brontë, Volume 1 (1857). Project Gutenberg eBook 1827 | Project Gutenberg | primary |
| SRC-0002 | Gaskell EC. The Life of Charlotte Brontë, Volume 2 (1857). Project Gutenberg eBook 1700 | Project Gutenberg | primary |
| SRC-0003 | Charlotte Brontë | Wikipedia | other |
| SRC-0004 | Brontë family | Wikipedia | other |
| SRC-0005 | Allison SP, Lobo DN. The death of Charlotte Brontë from hyperemesis gravidarum and refeeding syndrome: a new perspective. Clin Nutr. 2020;39(1):304-305 | PubMed (PMID 30777294) | scholarly |
| SRC-0006 | Weiss G. The death of Charlotte Brontë. Obstet Gynecol. 1991;78(4):705-708 | PubMed (PMID 1923177) | scholarly |
| SRC-0007 | Gezari J. The death of Charlotte Brontë | OUPblog (Oxford University Press) | other |
| SRC-0008 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the PUQE-based severity grading, the antiemetic steps and ondansetron counseling, thiamine before dextrose, weight-adjusted thromboprophylaxis, the thyroid interpretation, aneuploidy counseling, aspirin, tuberculosis screening, and the recorded deviation. |
| provenance review | not_started | Gaskell's Life (both volumes, public domain), two encyclopedia articles, two PubMed abstracts, and a publisher blog essay logged. The final illness, the death certificate, and the reported pregnancy are D; hyperemesis gravidarum, refeeding syndrome, typhoid, tuberculosis with Addison disease, and doubt about the pregnancy are R and conflict. No statement, decision, or health fact is attributed to her husband or father. |
| safe messaging review | not_started | Her death in pregnancy is recorded as a fact without detail. PHQ-9 and EPDS scores are below thresholds with item 9 and item 10 scored 0, so no safety assessment is required. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.